ArticleFrontiers in medicine2025
Effects of oral and transdermal estrogen on postoperative endometrial recovery after missed abortion: a retrospective longitudinal cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative efficacy and safety of medical and surgical management for missed miscarriage: a systematic review and meta-analysis.Frontiers in medicine · 2026Review
- The multiple positive effects of Honghua Ruyi Pills combined with estradiol valerate and dydrogesterone tablets on postoperative recovery in women after artificial abortion.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Missed abortion is a common complication of early pregnancy, and surgical evacuation remains the primary treatment. This study aims to evaluate the effects of no estrogen, oral estrogen, and transdermal estrogen on postoperative endometrial recovery and long-term reproductive outcomes. Methods: This retrospective longitudinal cohort study included women with early missed abortion who underwent surgical evacuation at Chengdu Women's and Children's Central Hospital between June 2023 and May 2025. Patients were stratified into three groups: no-estrogen, oral estrogen, and transdermal estrogen. Clinical data were collected at five time points: perioperative period, 1 week postoperatively, 1 month postoperatively, 3 months postoperatively, and 1 year postoperatively. Primary outcomes were endometrial thickness, intrauterine adhesion, adverse reactions, and 1-year pregnancy outcomes. Statistical analyses comprised the Results: A total of 561 women were included. Endometrial thickness at 1 and 3 months was significantly greater in both estrogen groups compared with the no-estrogen group ( Conclusion: Postoperative estrogen therapy promotes endometrial recovery after the surgical treatment of missed abortion. Both oral and transdermal estrogen treatments were effective, but transdermal administration provided better tolerability and adherence. Estrogen use may improve reproductive prognosis, warranting further prospective studies to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.